Podchaser Logo
Home
Repotrectinib & Capivasertib

Repotrectinib & Capivasertib

Released Thursday, 23rd November 2023
Good episode? Give it some love!
Repotrectinib & Capivasertib

Repotrectinib & Capivasertib

Repotrectinib & Capivasertib

Repotrectinib & Capivasertib

Thursday, 23rd November 2023
Good episode? Give it some love!
Rate Episode

FDA has approved two new kinase inhibitors: one for ROS1 (+) NSCLC and one for PIK3CA/AKT/PTEN altered breast cancer.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features